Congenital heart disease management continues to improve at a rapid pace, with recent decades having remarkable advances in transcatheter procedures, minimally invasive surgery, and even prenatal intervention. However, it is crucial to acknowledge the unique challenges encountered in patient care, such as late presentation and the need to minimize fluoroscopy and contrast agents, especially in vulnerable populations like small children and pregnant women. Moreover, staying abreast of emerging techniques and devices is essential. This underscores the necessity for a customized approach in patient management. Interventional pediatric cardiologists and cardiac surgeons must broaden their expertise to effectively address congenital heart diseases in both pediatric and adult patients.
This Research Topic aims to delve into contemporary surgical and non-surgical interventions for treating congenital and structural heart diseases across various age groups. It encompasses a spectrum of catheter-based procedures, practical intervention insights, and minimally invasive surgical methodologies. Furthermore, it will undertake a critical assessment of the merits and demerits of existing technologies utilized for similar therapeutic objectives, providing invaluable insights for enhancing clinical outcomes.
Led by a diverse global team of esteemed experts, this Research Topic aims to disseminate original studies, reviews, debates, and case reports dedicated to advancing the treatment of congenital heart diseases in both pediatric and adult populations. The topics to be explored encompass, but are not limited to:
- Innovative strategies to reduce fluoroscopy and contrast usage in catheter-based interventions for congenital and structural heart diseases;
- Tailored catheter-based interventions designed for late-presenting patients with congenital and structural heart diseases;
- Advancements in minimally invasive surgical techniques for congenital and structural heart diseases;
- Adoption of innovative devices and methodologies in the management of congenital and structural heart diseases;
- Fetal and prenatal interventions;
Congenital heart disease management continues to improve at a rapid pace, with recent decades having remarkable advances in transcatheter procedures, minimally invasive surgery, and even prenatal intervention. However, it is crucial to acknowledge the unique challenges encountered in patient care, such as late presentation and the need to minimize fluoroscopy and contrast agents, especially in vulnerable populations like small children and pregnant women. Moreover, staying abreast of emerging techniques and devices is essential. This underscores the necessity for a customized approach in patient management. Interventional pediatric cardiologists and cardiac surgeons must broaden their expertise to effectively address congenital heart diseases in both pediatric and adult patients.
This Research Topic aims to delve into contemporary surgical and non-surgical interventions for treating congenital and structural heart diseases across various age groups. It encompasses a spectrum of catheter-based procedures, practical intervention insights, and minimally invasive surgical methodologies. Furthermore, it will undertake a critical assessment of the merits and demerits of existing technologies utilized for similar therapeutic objectives, providing invaluable insights for enhancing clinical outcomes.
Led by a diverse global team of esteemed experts, this Research Topic aims to disseminate original studies, reviews, debates, and case reports dedicated to advancing the treatment of congenital heart diseases in both pediatric and adult populations. The topics to be explored encompass, but are not limited to:
- Innovative strategies to reduce fluoroscopy and contrast usage in catheter-based interventions for congenital and structural heart diseases;
- Tailored catheter-based interventions designed for late-presenting patients with congenital and structural heart diseases;
- Advancements in minimally invasive surgical techniques for congenital and structural heart diseases;
- Adoption of innovative devices and methodologies in the management of congenital and structural heart diseases;
- Fetal and prenatal interventions;